ASX Mkt. Sensitive<p>Chimeric Therapeutics ( <a href="https://mastodon-grafa.social/tags/CHM" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CHM</span></a> ) has released " CHM CDH17 ADVANCES TO DOSE LEVEL 2 " on Wed 21 May at 09:38 AEST <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>media</span></a> <a href="https://mastodon-grafa.social/tags/live" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>live</span></a> <a href="https://mastodon-grafa.social/tags/ASX" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ASX</span></a> <br><a href="https://grafa.com/asset/chimeric-therapeutics-ltd-1184-chm.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=chm.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/chimeric-thera</span><span class="invisible">peutics-ltd-1184-chm.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=chm.asx</span></a></p>